US Patent 10005737 Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
Patent 10005737 was granted and assigned to Vertex Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+171 characters)
Article
Patent abstract
The present invention relates to the novel regioselective syntheses of 2,4-disubstituted pyrimidines through sequential nucleophilic aromatic substitutions.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jean-Damien Charrier0
Michael Edward O'Donnell0
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100057370
Date of Patent
June 26, 2018
0Patent Application Number
153586340
Date Filed
November 22, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 1 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10005737 Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10005737
Date of patent
June 26, 2018
Patent application number
15358634
Date Filed
November 22, 2016
Patent primary examiner
Find more entities like US Patent 10005737 Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.